Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer.
about
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinomaNovel Immunotherapeutic Approaches for Head and Neck Squamous Cell CarcinomaPeripheral blood immune cell methylation profiles are associated with nonhematopoietic cancersExpression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue.Increased malignancy of oral squamous cell carcinomas (oscc) is associated with macrophage polarization in regional lymph nodes - an immunohistochemical studyDUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma.Hydrogels and scaffolds for immunomodulationPD-1/SHP-2 inhibits Tc1/Th1 phenotypic responses and the activation of T cells in the tumor microenvironmentChemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer.Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.Critical weight loss predicts poor prognosis in nasopharyngeal carcinomaEnhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice.CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma.Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy.The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.Immunotherapy for head and neck cancer: the future of treatment?Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.Change in CD3ζ-chain expression is an independent predictor of disease status in head and neck cancer patients.A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.Establishment of Synergistic Chemoimmunotherapy for Head and Neck Cancer Using Peritumoral Immature Dendritic Cell Injections and Low-Dose Chemotherapies.Predictors of Clinicopathologic Stage Discrepancy in Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study.
P2860
Q26752515-9142C72A-650B-4264-8514-E55BC2234476Q28071998-96265602-A2E8-43F8-96D2-B4E881DEDAA6Q28387330-259B4EFE-132C-4B71-B7C6-BD8F1DB8B9C3Q33562569-813D90C7-AC4F-4F26-944D-23BA83CF4A44Q34468743-213B47CE-0F17-4607-B709-3DD86E10778CQ34714447-27C9C342-241C-4E87-8AC7-BC0E26AD48FDQ34725541-EF6F336B-7714-4F3A-91A7-592A69D37AAFQ35044301-44311A31-12B1-455F-9B80-EA0263C77549Q35837683-6462E3CA-B2ED-4540-93A9-D77547296689Q36489379-A7876115-B177-4BD2-9285-F7BF41C5EECCQ36634090-F442BF45-A90B-4796-A537-D4896F018D29Q36688932-F5DEF737-A033-4D83-80F7-2EB0253ACEA7Q37079094-6150AD52-0C69-4FB7-BFA6-DD4E8E35F1FBQ37185840-443E9741-B1CA-49D3-9C19-A3F268E6FC4FQ38079588-D2C55F64-E70B-4794-AEE8-044B2C6FAB3DQ38736238-35225D3A-82DB-4055-B979-2E340EB00793Q38781955-C0AF455F-EB3C-494B-AA81-4A68DE421CC0Q40903579-E5E12D95-B65B-4981-9844-12984D33EDC2Q41349125-4A4A10CA-AAED-4E42-AD2C-5FB3639ABB70Q43616374-76324BE3-ADBF-4896-865C-0FF6CB3BCB35Q47096374-1E020A9D-E6E4-4061-8D68-B4876F7D59DBQ50078313-6136FB38-0AD0-4B0F-AAB3-3E62D20B5434
P2860
Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recognizing and reversing the ...... nment of head and neck cancer.
@en
Recognizing and reversing the ...... nment of head and neck cancer.
@nl
type
label
Recognizing and reversing the ...... nment of head and neck cancer.
@en
Recognizing and reversing the ...... nment of head and neck cancer.
@nl
prefLabel
Recognizing and reversing the ...... nment of head and neck cancer.
@en
Recognizing and reversing the ...... nment of head and neck cancer.
@nl
P2093
P2860
P1433
P1476
Recognizing and reversing the ...... nment of head and neck cancer.
@en
P2093
Andrew G Sikora
Charles C L Tong
Johnny Kao
P2860
P2888
P304
P356
10.1007/S12026-012-8306-6
P577
2012-12-01T00:00:00Z